精子胺增强了抗瘤免疫反应和乳腺癌免疫疗法敏感性
Xinyu Yang1,2, Yaxin Feng1,2, Ruxin Wang1,2
1Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Breast Tumor Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China.
Journal of Cancer
|September 17, 2025
概括
提高精子胺代谢可以增强乳腺癌的抗瘤免疫力. 这一策略刺激CD8+T细胞,改善对免疫疗法和化疗的反应.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 代谢学 代谢学 代谢学
背景情况:
- 精子胺代谢影响瘤进展和免疫反应,但其在乳腺癌中的作用尚未完全理解.
- 了解精氨酸对瘤微环境的影响对于开发新型治疗策略至关重要.
研究的目的:
- 为了研究精子胺在乳腺癌免疫力中的作用.
- 探索精子胺补充剂在增强抗瘤反应和免疫疗法的疗效方面的治疗潜力.
主要方法:
- 综合的多omics分析,包括批量和单细胞RNA测序.
- 免疫组织化学和多重免疫组织化学 (IHC/mIHC) 验证.
- 在体外和体内实验涉及外源性精子胺补充的实验.
主要成果:
- 在内精激素水平和CD8+ T细胞透和激活标记物 (GZMB+CD8+ T细胞) 之间发现了正相关性.
- 乳腺癌样本中精氨酸的产量增加与激活的CD8+ T细胞的增加相关.
- 外源性精氨酸补充直接促进了CD8+T细胞激活,并在体内增强了抗瘤免疫力.
- 精子胺补充剂改善了对抗PD-1免疫疗法与化疗相结合的敏感性.
结论:
- 增强精素代谢是一种有前途的策略,可以增强CD8+T细胞功能.
- 精子胺补充剂可以重振抗瘤免疫力.
- 这种方法有可能提高检查点阻断免疫疗法在乳腺癌治疗中的有效性.
相关概念视频
Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
Drugs that Stabilize Microtubules
2.6K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.6K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K


